# Peyton Marshall

> Peyton Marshall is the founder, Chairman, and CEO of LeveragePoint, a Newton, Massachusetts SaaS company that helps B2B firms quantify, communicate, and capture the economic value of what they sell. An economist by training with a PhD from MIT, he spent twelve years in investment banking in London at UBS and Goldman Sachs, then fifteen years as a CFO and operator in healthcare and IT companies, before founding LeveragePoint in 2009 to turn value-based pricing from a theory into an everyday sales tool. He has grown the company to multi-million-dollar revenue without raising venture capital.

- **Role:** Founder, Chairman and CEO at LeveragePoint Innovations
- **Organizations:** LeveragePoint Innovations Inc., Panacos Pharmaceuticals, EPIX Pharmaceuticals, The Medicines Company, Goldman Sachs, Union Bank of Switzerland (UBS), Vanderbilt University
- **Nationality:** American
- **Education:** AB in Economics, Davidson College, PhD in Economics, Massachusetts Institute of Technology
- **Known for:** Founded and built LeveragePoint, a SaaS leader in value-based pricing and value selling, growing it to multi-million-dollar revenue largely without venture capital, Served as CFO of The Medicines Company through its IPO and the commercial launch of Angiomax, Head of European product development at Goldman Sachs

## Career timeline

- **—** — Earned an AB in Economics from Davidson College
- **—** — Earned a PhD in Economics from MIT
- **—** — Served on the faculty of the Economics Department at Vanderbilt University
- **—** — Spent 12 years as an investment banker in London at Union Bank of Switzerland and at Goldman Sachs, where he was head of European product development
- **—** — CFO of The Medicines Company through its IPO and the commercial launch of Angiomax
- **—** — CFO of EPIX Pharmaceuticals
- **—** — CFO and Acting CEO of Panacos Pharmaceuticals
- **2009** — Founded LeveragePoint Innovations, a SaaS platform for value-based pricing and selling
- **2012** — LeveragePoint raised seed funding (latest raise approx. $710K total)

## Achievements

- Founded and built LeveragePoint, a SaaS leader in value-based pricing and value selling, growing it to multi-million-dollar revenue largely without venture capital
- Served as CFO of The Medicines Company through its IPO and the commercial launch of Angiomax
- Head of European product development at Goldman Sachs
- Earned a PhD in Economics from MIT and taught economics at Vanderbilt University

## Latest updates

- **—** — Continues to lead LeveragePoint as Founder, Chairman and CEO from Newton, Massachusetts.

## Links

- Website: https://leveragepoint.com
- LinkedIn: http://www.linkedin.com/in/peyton-marshall-805a416
- Twitter/X: http://www.twitter.com/LeveragePoint

---

Profile page: https://yespress.io/peyton-marshall
Published by YesPress — https://yespress.io
Last updated: 2026-06-21